<- Go Home

Provexis plc

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. The company offers syrup and powder versions of Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke used in various foods, beverages, and dietary supplement formats. It also provides Fruitflow+ Omega-3, a dietary supplement product. The company sells its products through e-commerce website and distributors. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.

Market Cap

GBP 29.6M

Volume

902.5K

Cash and Equivalents

GBP 523.3K

EBITDA

N/A

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

GBP 429.0K

Profit Margin

49.24%

52 Week High

GBP 0.02

52 Week Low

GBP 0.01

Dividend

N/A

Price / Book Value

25.87

Price / Earnings

-48.28

Price / Tangible Book Value

25.87

Enterprise Value

GBP 28.5M

Enterprise Value / EBITDA

N/A

Operating Income

-GBP 614.2K

Return on Equity

125.49%

Return on Assets

-46.13

Cash and Short Term Investments

GBP 523.3K

Debt

N/A

Equity

GBP 610.9K

Revenue

GBP 871.3K

Unlevered FCF

-GBP 324.4K

Sector

Personal Care Products

Category

N/A

Company Stock Pitches